Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

EBF Workshop Presentation, Lisbon

Stuart’s presentation, entitled General Principles of Stability Testing: What Is A Single Source? formed part of the EBF’s Industry input into ICH M10: Experimental data as the cornerstone for a science driven bioanalytical guideline event.

The aim of the meeting was to share and discuss data and experience related to BMV and analysis and to propose industry’s best practice recommendations for consideration in different areas of the proposed new guideline. 

The two-day meeting consisted of an update on recent industry developments related to BMV, including general feedback from the sister meeting organised by the AAPS (in collaboration with JBF and EBF). 

Attendees also benefited from presentations, data driven workshops and the sharing of experimental data gathered from recent and targeted surveys on items such as ISR, LBA dilution testing and selectivity or interference testing. The meeting ended with suggestions for improvement and a proposed way forward. 

Stuart’s presentation focused on the necessity for stability tests to support study samples, design testing so that dependent variable, independent variables and experimental variables are defined and controlled, and suggested that a single sample (with replicate analysis) is sufficient for each stability assessment at each concentration.

To view the presentation, visit the EBF website 

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.